Updated US FDA Guidance For The Gene Therapy Industry Key Changes And Areas Of Increased Focus

In January 2020, the United States Food and Drug Administration (FDA) released several new or updated guidance documents pertaining to human gene therapy products. The guidance documents address product development and clinical trial design in general, as well as for specific disease indications. Several key changes that will impact developers of gene therapies are summarized in this white paper. 

 

GET THE WHITE PAPER

Field will not be visible to web visitor
By completing this form, your information may be shared with our sponsor. See our privacy policy.
Copyright 2020 Industry Dive | Privacy Policy | Terms of Use